» Articles » PMID: 24412922

Broadly Neutralizing Hemagglutinin Stalk-specific Antibodies Require FcγR Interactions for Protection Against Influenza Virus in Vivo

Overview
Journal Nat Med
Date 2014 Jan 14
PMID 24412922
Citations 500
Authors
Affiliations
Soon will be listed here.
Abstract

Neutralizing antibodies against influenza viruses have traditionally been thought to provide protection exclusively through their variable region; the contributions of mechanisms conferred by the Fc domain remain controversial. We investigated the in vivo contributions of Fc interactions with their cognate receptors for a collection of neutralizing anti-influenza antibodies. Whereas five broadly neutralizing monoclonal antibodies (bNAbs) targeting the conserved stalk region of hemagglutinin (HA) required interactions between the antibody Fc and Fc receptors for IgG (FcγRs) to confer protection from lethal H1N1 challenge, three strain-specific monoclonal Abs (mAbs) against the variable head domain of HA were equally protective in the presence or absence of FcγR interactions. Although all antibodies blocked infection, only anti-stalk bNAbs were capable of mediating cytotoxicity of infected cells, which accounts for their FcγR dependence. Immune complexes generated with anti-HA stalk mAb efficiently interacted with FcγRs, but anti-HA head immune complexes did not. These results suggest that FcγR binding capacity by anti-HA antibodies was dependent on the interaction of the cognate Fab with antigen. We exploited these disparate mechanisms of mAb-mediated protection to reengineer an anti-stalk bNAb to selectively enhance FcγR engagement to augment its protective activity. These findings reveal a previously uncharacterized property of bNAbs and guide an approach toward enhancing mAb-mediated antiviral therapeutics.

Citing Articles

Cross-Reactive Fc-Mediated Antibody Responses to Influenza HA Stem Region in Human Sera Following Seasonal Vaccination.

Nishiyama A, Nogimori T, Masuta Y, Matsuura T, Kase T, Kondo K Vaccines (Basel). 2025; 13(2).

PMID: 40006687 PMC: 11860798. DOI: 10.3390/vaccines13020140.


CD47 prevents Rac-mediated phagocytosis through Vav1 dephosphorylation.

Miller W, Mishra A, Sheedy C, Bond A, Gardner B, Montell D bioRxiv. 2025; .

PMID: 39990418 PMC: 11844498. DOI: 10.1101/2025.02.11.637707.


Increased Chemokine Production is a Hallmark of Rhesus Macaque Natural Killer Cells Mediating Robust Anti-HIV Envelope-Specific Antibody-Dependent Cell-Mediated Cytotoxicity.

Nohara J, Evangelous T, Berry M, Beck W, Mudrak S, Jha S Pathog Immun. 2025; 10(1):49-79.

PMID: 39911143 PMC: 11792536. DOI: 10.20411/pai.v10i1.734.


How Broadly Neutralising Antibodies Are Redefining Immunity to Influenza.

Steventon R, Stolle L, Thompson C Antibodies (Basel). 2025; 14(1.

PMID: 39846612 PMC: 11755579. DOI: 10.3390/antib14010004.


Administration of antigenically distinct influenza viral particle combinations as an influenza vaccine strategy.

Zhu X, Luo Z, Leonard R, Hamele C, Spreng R, Heaton N PLoS Pathog. 2025; 21(1):e1012878.

PMID: 39841684 PMC: 11753672. DOI: 10.1371/journal.ppat.1012878.


References
1.
Ahmed R, Oldstone M, Palese P . Protective immunity and susceptibility to infectious diseases: lessons from the 1918 influenza pandemic. Nat Immunol. 2007; 8(11):1188-93. PMC: 7097533. DOI: 10.1038/ni1530. View

2.
Li G, Chiu C, Wrammert J, McCausland M, Andrews S, Zheng N . Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells. Proc Natl Acad Sci U S A. 2012; 109(23):9047-52. PMC: 3384143. DOI: 10.1073/pnas.1118979109. View

3.
Bakkouri K, Descamps F, De Filette M, Smet A, Festjens E, Birkett A . Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection. J Immunol. 2010; 186(2):1022-31. DOI: 10.4049/jimmunol.0902147. View

4.
Alter G, Malenfant J, Altfeld M . CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods. 2004; 294(1-2):15-22. DOI: 10.1016/j.jim.2004.08.008. View

5.
Nimmerjahn F, Ravetch J . Analyzing antibody-Fc-receptor interactions. Methods Mol Biol. 2008; 415:151-62. DOI: 10.1007/978-1-59745-570-1_9. View